Search

ResMed Inc

Gesloten

SectorGezondheidszorg

226.81 -0.1

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

225

Max

229.33

Belangrijke statistieken

By Trading Economics

Inkomsten

1.1B

1.5B

Verkoop

32M

1.5B

K/W

Sectorgemiddelde

21.38

56.432

EPS

2.95

Dividendrendement

1.1

Winstmarge

104.075

Werknemers

11,370

EBITDA

-91M

493M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+5.22% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

1.10%

2.27%

Volgende Winsten

29 okt 2026

Volgende dividenddatum

24 sep 2026

Volgende Ex Dividend datum

12 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

952M

32B

Vorige openingsprijs

226.91

Vorige sluitingsprijs

226.81

Nieuwssentiment

By Acuity

43%

57%

110 / 339 Rangschikking in Healthcare

ResMed Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 sep 2026, 21:31 UTC

ResMed Inc. is seeing a modest increase in after-hours trading, reaching a peak return of 0.46% following Wednesday's close.

15 sep 2026, 22:02 UTC

Social Media

RBC Capital upgraded ResMed Inc to Outperform and raised its price target to $262, with shares trading roughly flat in after-market hours.

9 sep 2026, 20:07 UTC

Resmed Inc. shares are lower today amid broader market declines and inflationary pressures tied to rising crude oil prices and interest rate hike speculation.

8 sep 2026, 20:02 UTC

News

Resmed Inc shares are lower amid a broader decline in the Health Care Equipment sector, reflecting six consecutive sessions of lower closes.

4 sep 2026, 19:47 UTC

Resmed Inc shares are lower, continuing a recent downward trend. No specific news explains today's price movement amid rising Treasury yields and unchanged unemployment figures.

3 sep 2026, 22:16 UTC

Resmed Inc. remains roughly flat in after-market trading, with no specific news identified. The stock has faced recent pressure, finishing lower in the last three sessions.

2 sep 2026, 20:08 UTC

Resmed Inc. shares are lower today, reflecting broader market declines since Tuesday. The ADP report indicates slower job growth, impacting Federal Reserve rate considerations.

1 sep 2026, 23:16 UTC

News

ResMed Inc has initiated a $450 million accelerated share repurchase agreement, contributing to higher shares in after-market trading. Final settlement is set for December 2026.

31 aug 2026, 20:07 UTC

ResMed Inc shares are lower today, influenced by Fed officials' comments on inflation and interest rates. Earlier, shares briefly recovered above Friday's close.

28 aug 2026, 20:07 UTC

News

Resmed Inc shares are higher today, reaching a session high and exceeding their 20-day moving average amid rising U.S. Treasury yields and inflation concerns.

27 aug 2026, 19:36 UTC

Social Media

Resmed Inc's shares are lower amid concerns over its MatrixCare divestiture, which reflects a significant drop in valuation from its 2018 acquisition.

26 aug 2026, 20:07 UTC

Resmed Inc shares are lower today, influenced by a decline in the Health Care Equipment sub-sector. No specific company news was identified.

25 aug 2026, 23:36 UTC

Shares of Resmed Inc. rose in after-market trading, continuing an upward trend since Tuesday's close despite earlier declines. The stock remains above its 20-day moving average.

24 aug 2026, 23:56 UTC

Resmed Inc. shares are lower in after-market hours amid weak trading sentiment. No specific company news was identified to explain the decline.

21 aug 2026, 20:06 UTC

ResMed Inc shares are higher today, reflecting broader market trends. The stock remains above its 20-day moving average and near its one-month range.

20 aug 2026, 20:06 UTC

Shares of Resmed Inc. are lower amid rising crude oil prices and increasing U.S. Treasury yields, reflecting broader market trends. No specific company news was identified.

19 aug 2026, 20:02 UTC

Shares of Resmed Inc. are trading higher today, reflecting strong momentum and significant recovery from earlier session dips.

18 aug 2026, 19:41 UTC

News

ResMed Inc. plans a meeting with KeyBanc on August 26 in Montreal. Shares are trading higher since Monday's close, recovering from earlier fluctuations.

17 aug 2026, 20:06 UTC

News

ResMed Inc. shares are declining following a Q2 earnings report showing reduced operating margins and a $42 million charge related to safety actions.

14 aug 2026, 23:46 UTC

Resmed Inc. shares are lower in after-market hours amid broader market sentiment influenced by a surprising decline in U.S. retail sales for July.

13 aug 2026, 19:16 UTC

News

ResMed Inc reports Q2 revenue of $1.46 billion, matching estimates. Shares are higher amid investor sentiment despite challenges from rising costs and a safety charge.

12 aug 2026, 21:01 UTC

Resmed Inc. shares are trading lower in after-market hours, continuing a decline that began shortly after Wednesday's close. No specific news was identified.

11 aug 2026, 23:26 UTC

Resmed Inc. shares remained roughly flat in after-market hours, reflecting broader market conditions amid investor caution ahead of upcoming inflation data.

10 aug 2026, 20:02 UTC

Social Media
News

ResMed reported Q2 2026 sales of $1.46 billion, exceeding expectations. Shares are gaining today, despite earlier pulling back in the session.

8 aug 2026, 00:01 UTC

Resmed Inc. shares declined in after-market trading, moving below the 20-day moving average, despite earlier gains since Friday's close.

7 aug 2026, 23:41 UTC

News

ResMed shares declined after-market despite RBC Capital raising its price target to $244 and maintaining a Sector Perform rating.

6 aug 2026, 23:01 UTC

News

ResMed shares declined in after-market trading despite a fourth-quarter earnings beat. The company reported a non-GAAP EPS of $2.95 and revenue of $1.46 billion.

5 aug 2026, 19:11 UTC

News

ResMed Inc shares are higher as the company prepares for earnings on August 5, 2026, following a quarter that exceeded expectations.

4 aug 2026, 20:02 UTC

News

ResMed Inc shares are advancing, supported by strong cash flow and global growth. The stock has maintained a notable gain since Monday's close.

3 aug 2026, 21:02 UTC

News

ResMed Inc. shares are higher in after-market trading, supported by strong financials and a free cash flow margin of 31.7%.

Peer Vergelijking

Prijswijziging

ResMed Inc Prognose

Koersdoel

By TipRanks

5.22% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 241.417 USD  5.22%

Hoogste 320 USD

Laagste 213 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor ResMed Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

15 ratings

5

Buy

10

Hold

0

Sell

Sentiment

By Acuity

110 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat